These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34112803)

  • 1. Tumor microenvironmental cytokines bound to cancer exosomes determine uptake by cytokine receptor-expressing cells and biodistribution.
    Lima LG; Ham S; Shin H; Chai EPZ; Lek ESH; Lobb RJ; Müller AF; Mathivanan S; Yeo B; Choi Y; Parker BS; Möller A
    Nat Commun; 2021 Jun; 12(1):3543. PubMed ID: 34112803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dahuang Zhechong Pill suppresses colorectal cancer liver metastasis via ameliorating exosomal CCL2 primed pre-metastatic niche.
    Chen C; Yao X; Xu Y; Zhang Q; Wang H; Zhao L; Wen G; Liu Y; Jing L; Sun X
    J Ethnopharmacol; 2019 Jun; 238():111878. PubMed ID: 30986521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune suppressed tumor microenvironment by exosomes derived from gastric cancer cells via modulating immune functions.
    Liu J; Wu S; Zheng X; Zheng P; Fu Y; Wu C; Lu B; Ju J; Jiang J
    Sci Rep; 2020 Sep; 10(1):14749. PubMed ID: 32901082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum-derived exosomes from mice with highly metastatic breast cancer transfer increased metastatic capacity to a poorly metastatic tumor.
    Gorczynski RM; Erin N; Zhu F
    Cancer Med; 2016 Feb; 5(2):325-36. PubMed ID: 26725371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic psychological stress promotes lung metastatic colonization of circulating breast cancer cells by decorating a pre-metastatic niche through activating β-adrenergic signaling.
    Chen H; Liu D; Guo L; Cheng X; Guo N; Shi M
    J Pathol; 2018 Jan; 244(1):49-60. PubMed ID: 28940209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments.
    Brummer G; Fang W; Smart C; Zinda B; Alissa N; Berkland C; Miller D; Cheng N
    Oncogene; 2020 Mar; 39(11):2275-2289. PubMed ID: 31827233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of CCL2-CCR2-Glycosaminoglycan Axis Using a CCL2 Decoy Protein Attenuates Metastasis through Inhibition of Tumor Cell Seeding.
    Roblek M; Strutzmann E; Zankl C; Adage T; Heikenwalder M; Atlic A; Weis R; Kungl A; Borsig L
    Neoplasia; 2016 Jan; 18(1):49-59. PubMed ID: 26806351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Experimental Models of Breast Cancer Exosome Secretion, Characterization and Function.
    Pelissier Vatter FA; Lucotti S; Zhang H
    J Mammary Gland Biol Neoplasia; 2020 Dec; 25(4):305-317. PubMed ID: 33351162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone.
    Lu X; Kang Y
    J Biol Chem; 2009 Oct; 284(42):29087-96. PubMed ID: 19720836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
    Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
    Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Biodistribution and Immune Suppressive Effects of Breast Cancer-Derived Exosomes.
    Wen SW; Sceneay J; Lima LG; Wong CS; Becker M; Krumeich S; Lobb RJ; Castillo V; Wong KN; Ellis S; Parker BS; Möller A
    Cancer Res; 2016 Dec; 76(23):6816-6827. PubMed ID: 27760789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Cancer-Derived Exosomes Alter Macrophage Polarization
    Ham S; Lima LG; Chai EPZ; Muller A; Lobb RJ; Krumeich S; Wen SW; Wiegmans AP; Möller A
    Front Immunol; 2018; 9():871. PubMed ID: 29867925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds.
    Lança T; Costa MF; Gonçalves-Sousa N; Rei M; Grosso AR; Penido C; Silva-Santos B
    J Immunol; 2013 Jun; 190(12):6673-80. PubMed ID: 23686489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted remodeling of breast cancer and immune cell homing niches by exosomal integrins.
    Myint PK; Park EJ; Gaowa A; Kawamoto E; Shimaoka M
    Diagn Pathol; 2020 Apr; 15(1):38. PubMed ID: 32305065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinflammatory role of epithelial cell-derived exosomes in allergic airway inflammation.
    Kulshreshtha A; Ahmad T; Agrawal A; Ghosh B
    J Allergy Clin Immunol; 2013 Apr; 131(4):1194-203, 1203.e1-14. PubMed ID: 23414598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo.
    Lavender N; Yang J; Chen SC; Sai J; Johnson CA; Owens P; Ayers GD; Richmond A
    BMC Cancer; 2017 Jan; 17(1):88. PubMed ID: 28143493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-mediated therapeutic resistance in breast cancer.
    Tan C; Hu W; He Y; Zhang Y; Zhang G; Xu Y; Tang J
    Cytokine; 2018 Aug; 108():151-159. PubMed ID: 29609137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes.
    Jafarzadeh N; Safari Z; Pornour M; Amirizadeh N; Forouzandeh Moghadam M; Sadeghizadeh M
    J Cell Physiol; 2019 Apr; 234(4):3697-3710. PubMed ID: 30317554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
    Teng KY; Han J; Zhang X; Hsu SH; He S; Wani NA; Barajas JM; Snyder LA; Frankel WL; Caligiuri MA; Jacob ST; Yu J; Ghoshal K
    Mol Cancer Ther; 2017 Feb; 16(2):312-322. PubMed ID: 27980102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells.
    Liu Y; Xiang X; Zhuang X; Zhang S; Liu C; Cheng Z; Michalek S; Grizzle W; Zhang HG
    Am J Pathol; 2010 May; 176(5):2490-9. PubMed ID: 20348242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.